Jan 7, 2026 07:00AM
Dec 26, 2025 08:30AM
Dec 26, 2025 08:30AM
Nov 19, 2025 04:15AM
Nov 5, 2025 04:02PM
Nov 5, 2025 04:01PM
Oct 16, 2025 07:00AM Adicet Bio doses first patient in rheumatoid arthritis trial
Oct 16, 2025 07:00AM
Oct 7, 2025 06:45AM
Oct 7, 2025 06:45AM
Aug 13, 2025 04:11AM
Aug 7, 2025 04:01PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
May 6, 2025 05:43PM
May 6, 2025 04:01PM
Apr 17, 2025 07:01AM
Apr 17, 2025 07:00AM
Mar 6, 2025 05:20PM
Mar 6, 2025 04:01PM
Feb 27, 2025 07:02AM Adicet Bio (ACET) Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis
Feb 27, 2025 07:00AM
Feb 5, 2025 07:10AM
Feb 5, 2025 07:10AM
Jan 8, 2025 04:10PM
Jan 8, 2025 04:10PM
Dec 19, 2024 07:03AM
Dec 19, 2024 07:00AM Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Dec 18, 2024 07:00AM
Dec 18, 2024 07:00AM
Nov 18, 2024 04:00PM
Nov 18, 2024 04:00PM
Nov 18, 2024 07:09AM
Nov 18, 2024 07:00AM
Nov 16, 2024 09:00AM Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
Nov 7, 2024 06:14AM
Nov 6, 2024 04:00PM
Nov 6, 2024 04:00PM
Oct 16, 2024 07:01AM
Oct 16, 2024 07:00AM
Sep 30, 2024 07:00AM
Sep 19, 2024 07:02AM Adicet Bio (ACET): ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
Sep 19, 2024 07:00AM
Aug 19, 2024 07:01AM
Aug 19, 2024 07:00AM
Aug 14, 2024 06:11AM
Aug 13, 2024 07:44AM
Aug 13, 2024 07:00AM
Jul 8, 2024 07:00AM Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Jun 24, 2024 07:03AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All